BUDESONIDE/ FORMOTEROL FUMARATE DIHYDRATE INHALER (GoResp DigihalerĀ®)

Clinical Indication

Comments

Discontinued June 2024 – seeĀ MHRA alert

Date of classification

March 2024

Do not prescribe

Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.